Precision Molecular Pathology of Hodgkin Lymphoma, 1st ed. 2018 Molecular Pathology Library Series
Langue : Anglais
This text provides a comprehensive and up-to-date overview of Hodgkin lymphoma. The volume reviews every facet of the cancer in great detail, including pathology, pathobiology, molecular genetics, microenvironment, epidemiology, treatment, and new therapeutic advances. The specific role of the lymphoma microenvironment is addressed, and the relationship of Hodgkin lymphoma to related non-Hodgkin lymphomas is covered as well.
Written by experts in the field, Precision Molecular Pathology of Hodgkin Lymphoma is a valuable resource for oncologists, surgeons, pathologists, clinical trainees, and investigators engaged in the diagnosis, treatment, and research studies of this lymphoid neoplasm.
Introduction.- Clinical features.- Histopathology of Hodgkin lymphoma and closely related lymphomas.- Pathogenesis and molecular genetics of classical Hodgkin lymphoma.- The microenvironment in classical Hodgkin lymphoma.- Role of EBV in classical Hodgkin lymphoma.- Pathobiology of nodular lymphocyte predominant Hodgkin lymphoma.- Composite lymphomas and the relationship of Hodgkin lymphoma to Non-Hodgkin lymphomas.- Epidemiology and genetic risk factors.- Treatment and Prognosis.- Development of targeted therapies.
S. David Hudnall, MD
Professor of Pathology and Laboratory Medicine
Director, Hematopathology Program
Associate Medical Director, Precipio Diagnostics, LLC
Yale University School of Medicine
310 Cedar Street
New Haven, CT 06520
USA
Dr. Ralf Küppers
University of Duisburg-Essen
Department of Molecular Genetics
Institute of Cell Biology
Hufelandstr. 55
45122 Essen
Germany
Provides the most updated knowledge on Hodgkin lymphoma Supplemented with illustrative tables and full-color photomicrographs Written by experts in the field
Date de parution : 09-2018
Ouvrage de 236 p.
15.5x23.5 cm
Date de parution : 12-2017
Ouvrage de 236 p.
15.5x23.5 cm
Thème de Precision Molecular Pathology of Hodgkin Lymphoma :
Mots-clés :
microenvironment; EBV; nodular lymphocyte; non-Hodgkin lymphoma; targeted therapies
© 2024 LAVOISIER S.A.S.
